132 related articles for article (PubMed ID: 38373941)
1. Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient: a case report.
Tabarsi P; Maleki A; Abtahian Z; Khabbaz A; Fereydouni Z; Rezaie J; Tavakoli M; Sanati PY; Salehi-Vaziri M
BMC Infect Dis; 2024 Feb; 24(1):216. PubMed ID: 38373941
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
4. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
5. Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report.
Bedoya-Joaqui V; Gutiérrez-López MI; Caicedo PA; Villegas-Torres MF; Albornoz-Tovar LL; Vélez JD; Hidalgo-Cardona A; Tobón GJ; Cañas CA
J Med Case Rep; 2023 May; 17(1):194. PubMed ID: 37173711
[TBL] [Abstract][Full Text] [Related]
6. Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review.
Wee LE; Tan JY; Oon LLE; Pena AMT; Quek JKS; Venkatachalam I; Ko KK; Wijaya L
Int J Infect Dis; 2023 Apr; 129():236-239. PubMed ID: 36608786
[TBL] [Abstract][Full Text] [Related]
7. [P323L Mutation in a Case with Prolonged SARS-CoV-2 PCR Positivity].
Yücebağ E; Arslan N; Tok Y; Nohut OK; Salman Yılmaz S; Kuşkucu MA; Midilli K
Mikrobiyol Bul; 2023 Jul; 57(3):490-497. PubMed ID: 37462312
[TBL] [Abstract][Full Text] [Related]
8. Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.
Cos Esquius ML; López Montesinos I; Gimeno Martinez R; Eguía Núñez J; Caballero-Rabasco MA; Sánchez González B; López García A; Mellibovsky L
Clin Immunol; 2022 Feb; 235():108789. PubMed ID: 34197951
[No Abstract] [Full Text] [Related]
9. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
10. [Patient with Good's syndrome and COVID-19. Report of a clinical case].
Maldonado-Domínguez ED; O Farrill-Romanillos PM
Rev Med Inst Mex Seguro Soc; 2022 Jul; 60(4):474-479. PubMed ID: 35819306
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
Keshavarz Valian N; Pourakbari B; Asna Ashari K; Hosseinpour Sadeghi R; Mahmoudi S
J Med Virol; 2022 Apr; 94(4):1450-1456. PubMed ID: 34786736
[TBL] [Abstract][Full Text] [Related]
12. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
14. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
17. [COVID-19 in adults with antibody deficiencies].
López AL; Torre MG; Paolini MV; Juri MC; Fernández Romero DS
Medicina (B Aires); 2021; 81(3):478-481. PubMed ID: 34137714
[TBL] [Abstract][Full Text] [Related]
18. Universal screening for SARS-CoV-2 infection: a rapid review.
Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
20. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
